Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2026-02-22 @ 7:25 AM
Study NCT ID:
NCT02294656
Status:
COMPLETED
Last Update Posted:
2018-09-11
First Post:
2014-11-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide
Sponsor:
Soll Eye
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-11
Start Date Type:
ACTUAL
Primary Completion Date:
2018-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-09
Completion Date Type:
ACTUAL
First Submit Date:
2014-11-04
First Submit QC Date:
None
Study First Post Date:
2014-11-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-08
Last Update Post Date:
2018-09-11
Last Update Post Date Type:
ACTUAL